# Yang Ou

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yang-ou/

## Facts

| Field | Value |
| --- | --- |
| Citations | 634 |
| Field | Cardiovascular Function and Risk Factors |
| h-index | 12 |
| i10-index | 15 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5110695417 |
| ORCID iD | 0009-0004-5020-7912 |
| Works | 31 |

## Researcher papers

- [Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure](https://scholariq.org/papers/tirzepatide-reduces-lv-mass-and-paracardiac-adipose-tissue-in-obesity-related/)
- [Salivary diagnostics: opportunities and challenges](https://scholariq.org/papers/salivary-diagnostics-opportunities-and-challenges/)
- [Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity](https://scholariq.org/papers/effects-of-tirzepatide-on-the-clinical-trajectory-of-patients-with-heart-failure/)
- [Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU+P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC).](https://scholariq.org/papers/randomized-placebo-controlled-phase-iii-trial-of-sunitinib-in-combination-with/)
- [Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity](https://scholariq.org/papers/interplay-of-chronic-kidney-disease-and-the-effects-of-tirzepatide-in-patients/)
- [Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF](https://scholariq.org/papers/impact-of-body-mass-index-central-adiposity-and-weight-loss-on-the-benefits-of/)
- [The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review](https://scholariq.org/papers/the-prognostic-significance-of-pretreatment-serum-glutamyltranspeptidase-in/)
- [\[alpha1,2-fucosyltransferase gene transfection influences on biological behavior of ovarian carcinoma-derived RMG-I cells\].](https://scholariq.org/papers/alpha1-2-fucosyltransferase-gene-transfection-influences-on-biological-behavior/)
- [Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials](https://scholariq.org/papers/efficacy-and-safety-of-car-modified-t-cell-therapy-in-patients-with-relapsed-or/)
- [Progressive Diffuse Large B-cell Lymphoma with <i>TP53</i> Gene Mutation Treated with Chidamide-Based Chemotherapy](https://scholariq.org/papers/progressive-diffuse-large-b-cell-lymphoma-with-i-tp53-i-gene-mutation-treated/)

## Researcher topics

- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.